stenosi
transplant
renal
arteri
earli
complic
earli
diagnosi
manag
necessari
prevent
allograft
dysfunct
sever
complic
aris
sever
hypertens
surveil
bk
viru
commonli
done
transplant
center
bk
viremia
similarli
common
earli
period
due
intens
untreat
bk
viremia
progress
bkvan
lead
transplant
although
cmv
infect
known
occur
associ
concomit
bk
viremia
tra
describ
describ
girl
present
associ
caucasian
girl
esrd
secondari
injuri
birth
requir
temporari
rrt
form
pd
week
month
age
pd
discontinu
month
age
due
recurr
fungal
periton
abl
maintain
stabl
electrolyt
good
urin
output
pd
year
age
receiv
deceas
donor
kidney
transplant
adult
donor
donor
kidney
cm
length
singl
renal
arteri
vein
kdpi
height
cm
centil
weight
kg
centil
time
transplant
five
antigen
mismatch
kidney
pretranspl
hypercoagul
workup
neg
allograft
place
donor
renal
arteri
anastomos
recipi
aorta
donor
renal
vein
recipi
ivc
via
anastomosi
use
prolen
sutur
bilater
nativ
nephrectomi
right
kidney
cm
left
kidney
cm
length
perform
time
transplant
prevent
dehydr
episod
polyur
prior
transplant
also
thought
donor
kidney
would
littl
difficult
fit
small
patient
event
otherwis
unremark
heparin
administ
abdomin
fascia
close
pd
skin
close
monocryl
subcuticular
sutur
cit
hour
minut
wit
minut
ebv
cmv
mismatch
donor
posit
recipi
neg
excis
left
parathyroid
nodul
day
prior
transplant
mri
neck
done
persist
hypercalcemia
phosphaturia
normophosphatemia
suppress
serum
intact
pth
elev
pthrp
pgml
fgf
shown
left
parathyroid
nodul
histolog
excis
tissu
show
presenc
thymic
tissu
induct
done
thymoglobulin
total
mgkg
methylprednisolon
excel
graft
perfus
immedi
anastomosi
good
urin
output
hour
progress
becam
oligoanur
hour
anur
serum
creatinin
remain
pretranspl
level
mgdl
doppler
us
renal
transplant
show
poor
blood
flow
lead
emerg
abdomin
hour
earli
thrombu
found
renal
arteri
tip
underw
thrombectomi
kidney
kept
cold
back
bench
renal
arteri
right
common
iliac
arteri
perform
use
prolen
sutur
abdomen
left
open
patch
mesh
ioband
place
mesh
receiv
heparin
infus
babi
aspirin
renal
function
remain
derang
dyselectrolytemia
elev
serum
creatinin
peak
mgdl
requir
initi
hd
open
transplant
kidney
biopsi
perform
pod
show
featur
atn
without
reject
mmf
start
pod
initi
tacrolimu
delay
due
dgf
urin
output
gradual
improv
pod
dialysi
requir
pod
patch
remov
fascia
close
pd
skin
close
monocryl
subcuticular
fashion
discharg
home
pod
tacrolimu
mmf
steroid
aspirin
prophylaxi
consist
valganciclovir
nystatin
month
start
amlodipin
mild
asymptomat
hypertens
ureter
stent
remov
week
serum
trough
tacrolimu
level
remain
goal
ngml
per
center
protocol
intermitt
elev
requir
dose
reduct
later
cours
complic
multipl
hospit
admiss
due
viral
respiratori
ill
uti
febril
neutropenia
episod
manag
appropri
antibiot
reduc
immunosuppress
support
measur
aspirin
discontinu
month
due
develop
spontan
bruis
mmf
held
month
due
sever
neutropenia
bk
viremia
latter
start
month
peak
copiesml
arup
laboratori
normal
copiesml
quantit
pcr
serum
month
figur
leflunomid
mg
daili
start
month
renal
function
remain
stabl
baselin
serum
creatinin
mgdl
transplant
biopsi
perform
histori
gross
hematuria
hydronephrosi
cmv
ebv
dna
pcr
remain
neg
throughout
month
present
hypertens
emerg
pre
appar
follow
anoth
episod
respiratori
ill
later
found
secondari
coronaviru
parainfluenza
infect
medic
includ
tacrolimu
prednisolon
amlodipin
valganciclovir
leflunomid
serum
trough
tacrolimu
level
ngml
serum
creatinin
elev
mgdl
averag
sbp
rang
mm
hg
despit
multipl
antihypertens
includ
continu
nicardipin
infus
second
day
admiss
develop
gener
seizur
bp
mm
hg
mri
brain
show
chang
consist
pre
antihypertens
therapi
augment
combin
nicardipin
infus
hydralazin
carvedilol
clonidin
furosemid
amlodipin
losartan
minoxidil
echocardiogram
show
lvh
lvmi
doppler
us
allograft
show
decreas
resist
indic
tardu
parvu
waveform
hydronephrosi
duplex
studi
renal
arteri
show
extrem
elev
veloc
proxim
renal
arteri
ostial
renal
proxim
renal
mid
renal
distal
renal
arteri
cm
confirm
proxim
tra
renal
function
continu
worsen
peak
serum
creatinin
mgdl
losartan
discontinu
serum
bk
pcr
load
copiesml
neg
cmv
ebv
pcr
urin
bk
pcr
load
million
copiesml
urin
cytolog
decoy
cell
sent
percutan
transplant
kidney
biopsi
show
mild
diffus
interstiti
inflamm
heavier
medulla
lymphocyt
mononuclear
cell
associ
mild
lymphocyt
tubul
moder
ifta
hemorrhag
edema
endotheli
peritubular
stain
neg
definit
intranuclear
inclus
seen
immunohistochem
stain
posit
epitheli
cell
distal
proxim
tubul
chang
consist
bkvan
treat
ivig
increas
dose
leflunomid
mg
daili
cessat
tacrolimu
clinic
cours
complic
oliguria
pulmonari
edema
eventu
requir
hd
mechan
ventil
hd
discontinu
day
later
improv
pulmonari
function
howev
refractori
hypertens
persist
despit
multipl
antihypertens
agent
underw
convent
digit
subtract
angiogram
show
sever
anastomot
stenosi
occlus
renal
arteri
figur
preprocedur
gradient
mm
hg
across
stenosi
success
pta
stent
mm
balloon
mount
uncoat
stent
monorail
xienc
sierra
abbott
laboratori
transplant
renal
arteri
done
immedi
improv
blood
flow
gradient
reduct
mm
hg
bp
normal
within
hour
averag
sbp
mm
hg
intermitt
elev
mm
hg
repeat
doppler
us
show
normal
resist
indic
vascular
waveform
maintain
aspirin
follow
stent
transplant
renal
arteri
time
discharg
serum
creatinin
back
baselin
mgdl
bp
control
antihypertens
amlodipin
clonidin
discharg
medic
includ
aspirin
prednison
tacrolimu
repeat
echocardiogram
show
decreas
lvmi
month
later
show
stabl
baselin
serum
creatinin
mgdl
control
bp
two
antihypertens
agent
doppler
renal
transplant
sonogram
duplex
studi
renal
arteri
show
normal
waveform
veloc
respect
bk
viremia
resolv
month
leflunomid
discontinu
mmf
restart
bk
viremia
nephropathi
increasingli
recogn
import
caus
renal
allograft
incid
bk
viremia
within
first
year
bkvan
report
kidney
transplant
gener
high
serum
viral
load
suggest
warrant
close
renal
function
although
patient
high
serum
viral
load
initi
perform
biopsi
due
stabl
graft
function
perform
renal
biopsi
usual
prompt
allograft
dysfunct
studi
suggest
persist
bk
viruria
viremia
appropri
indic
hand
higher
rate
biopsi
may
encount
earli
stage
diseas
parenchym
involv
cytopath
chang
obviou
biopsi
mostli
due
focal
natur
due
signific
ifta
patient
renal
transplant
ureter
stenosi
bkvan
known
complic
bk
infect
howev
presenc
bk
infect
along
tra
describ
wide
accept
pathogenesi
bkvan
character
ascend
infect
uroepitheli
cell
viral
replic
renal
tubular
epitheli
cell
lead
cellular
loss
therebi
denud
epitheli
monolay
tubul
viru
leak
tissu
bloodstream
inflammatori
cell
infiltr
interstitium
lead
vascular
spread
viru
may
lead
dissemin
viru
tissu
histor
polyomavirus
bk
jc
viru
known
infect
uroren
epitheli
neural
cell
howev
subsequ
report
describ
bk
viru
infect
reactiv
larg
number
target
cell
includ
one
affect
inflamm
ischemia
reperfus
injuri
predominantli
immunocompromis
host
target
tissu
organ
system
includ
liver
retina
lung
salivari
gland
peripher
blood
leukocyt
human
umbil
cord
vein
umbil
cell
pancreat
cell
heart
skelet
bk
viru
also
shown
tropism
vascular
endotheli
cell
caus
immun
respons
upregul
gene
associ
cell
bk
infect
also
activ
interferon
signal
endotheli
cell
increas
mrna
level
mani
uptak
bkv
particl
endotheli
cell
liver
sinusoid
renal
shown
anim
indic
endotheli
cell
might
provid
initi
immun
defens
bkv
infect
furthermor
vitro
studi
show
bk
viru
exhibit
prolong
viral
protein
express
least
month
low
yield
infecti
progeni
delay
cell
death
henc
maintain
antivir
defens
endotheli
rais
possibl
role
bk
viru
induc
vascular
stenosi
especi
prior
histori
renal
arteri
thrombosi
thrombectomi
possibl
vascular
injuri
case
describ
report
upregul
cell
prolifer
gene
bk
infect
endotheli
cell
could
lead
product
granul
tissu
lead
stenosi
renal
arteri
inde
ureter
stenosi
one
known
associ
bk
infect
usual
occur
month
correspond
peak
onset
bk
viru
reactiv
kidney
transplant
recipi
wide
accept
theori
ureter
epithelium
damag
ischemia
inflamm
support
bk
infect
replac
granul
tissu
lead
abl
provid
histolog
evid
bk
infect
transplant
renal
arteri
due
invas
natur
procedur
potenti
risk
complic
contrast
infect
renal
proxim
tubular
epitheli
cell
elicit
effici
innat
immun
respons
bkv
infect
lead
releas
mani
progeni
virion
loss
cell
monolay
cytopath
effect
bk
viru
also
demonstr
podocyt
mesangi
cell
glomerular
endotheli
cell
along
epitheli
cell
bladder
suggest
cell
mount
effect
antivir
respons
may
contribut
glomerular
inflamm
hemorrhag
cystiti
bkv
due
strong
product
infect
viral
persist
maintain
cell
oppos
endotheli
cell
describ
henc
seem
cell
respons
bkv
infect
simultan
occurr
bk
nephropathi
tra
patient
may
exampl
respons
death
renal
tubular
cell
prolifer
renal
arteri
endotheli
cell
bk
tropism
vascular
endotheli
cell
well
describ
clinic
report
describ
dissemin
bk
vasculopathi
multipl
organ
includ
skelet
muscl
kidney
heart
esophagu
histolog
proven
adult
renal
transplant
recipi
lead
death
renal
allograft
biopsi
show
immunoreact
polyomaviru
protein
capillari
endotheli
cell
tubular
lumen
studi
postul
bk
injuri
led
capillari
leakag
massiv
edema
along
microthrombot
event
caus
tissu
ischemia
multipl
report
describ
child
simultan
occurr
bk
nephropathi
tra
latter
presum
due
spread
bk
renal
tubular
epitheli
cell
vascular
endotheli
cell
tra
common
vascular
complic
seriou
potenti
revers
caus
hypertens
allograft
dysfunct
usual
present
month
year
report
incid
vari
wide
recent
studi
show
lower
incid
rate
within
year
risk
factor
includ
kink
arteri
placement
vascular
clamp
transplant
faulti
retriev
sutur
donor
arteri
atherosclerosi
fibrosi
intim
hyperplasia
prior
injuri
time
donat
anastomosi
prior
thrombosi
older
recipi
age
margin
donor
kidney
dgf
prolong
cit
acut
reject
cmv
infect
mainli
seroconvert
vascular
damag
may
occur
local
infect
mitogen
action
viral
gene
product
within
cell
vessel
cmv
infect
also
thought
augment
endotheli
direct
prolif
effect
vascular
endotheli
cell
lead
tra
anoth
lymphoma
lead
tra
secondari
extrins
compress
renal
arteri
describ
adult
patient
cmv
ebv
viremia
extrins
compress
renal
arteri
thrombu
thought
secondari
two
surgeri
lead
intravascular
volum
deplet
due
npo
statu
prolong
time
set
polyuria
support
evid
atn
biopsi
underw
thrombectomi
could
ad
insult
arteri
anastomosi
report
studi
risk
factor
tra
consist
best
knowledg
bk
infect
shown
risk
factor
tra
possibl
given
effect
endotheli
cell
outlin
one
drug
use
treatment
bk
infect
leflunomid
caus
cutan
necrot
vascul
associ
tra
endovascular
intervent
pta
without
stent
usual
therapi
tra
increas
risk
graft
loss
report
regardless
angioplasti
anoth
retrospect
studi
gedd
et
found
increas
risk
graft
loss
patient
tra
treat
angioplasti
vs
receiv
angioplasti
surgic
repair
reserv
case
angioplasti
unamen
patient
excel
outcom
pta
stent
placement
alon
patient
appear
develop
clinic
signific
tra
simultan
evid
florid
bkvan
resolut
phase
bk
viremia
howev
time
biopsi
could
caus
appar
observ
independ
risk
factor
develop
tra
bkvan
henc
definit
causat
establish
two
sole
report
could
mere
incident
find
rapid
clinic
improv
pta
stent
placement
also
suggest
stenosi
may
definit
due
bk
infect
tissu
histolog
renal
arteri
demonstr
bk
infect
could
provid
definit
answer
obtain
due
sever
potenti
risk
procedur
also
hypertens
allograft
dysfunct
multifactori
henc
attribut
complic
due
tra
andor
bk
viremia
tra
bkvan
seriou
complic
rt
earli
diagnosi
necessari
improv
allograft
surviv
report
postul
bk
infect
could
risk
factor
tra
given
associ
studi
necessari
determin
possibl
causal
relationship
two
entiti
henc
may
worthwhil
look
evid
tra
studi
doppler
transplant
sonogram
andor
duplex
renal
arteri
studi
suggest
invas
studi
angiogram
patient
bk
viremia
hypertens
histolog
evid
bk
viru
particl
stenot
tissu
may
use
well
author
conflict
interest
disclos
sudha
mannemuddhu
nail
pekkucuksen
rachel
bush
felicia
john
collect
data
draft
initi
manuscript
review
revis
manuscript
kiran
upadhyay
collect
data
conceptu
studi
draft
initi
manuscript
critic
review
revis
manuscript
author
approv
final
manuscript
submit
agre
account
aspect
work
